Clinical Strategy
Clinical strategy that supports approval and adoption
We support health and medical technology companies with clinical strategy, evidence generation and study delivery, helping you demonstrate safety, performance and value across the product lifecycle.
50+
Years combined experience
100+
Life science projects delivered
20+
Global markets
01 - CLINICAL LANDSCAPE
Building the right clinical evidence
Key challenges we help you address
Clinical evidence is central to regulatory approval, market access and adoption. We help you plan, generate and maintain the evidence needed to support your product at every stage.
Evolving evidence expectations
Regulators and notified bodies expect stronger, more structured clinical evidence across the product lifecycle.
Clinical data gaps
Gaps in evidence can limit approvals, restrict claims and delay market access.
Study design and feasibility
Poorly designed studies can delay timelines, increase cost and fail to generate meaningful data.
Ongoing evidence requirements
Clinical evidence must be maintained post-approval through surveillance and follow-up activities
KEY STATISTICS
The scale of clinical evidence challenges
Clinical evidence requirements continue to increase across all product types. These figures highlight the pressure on teams to generate robust, regulatory-ready data.
80%
of manufacturers struggle to generate sufficient clinical evidence under MDR
47%
of commercialised companies feel equipped to manage their clinical trials
$23.5bn
Projected global device clinical trials market by 2030
60%+
of high-risk manufacturers have outsourced their Clinical Evaluation Reports
02 - OUR CAPABILITIES
Clinical strategy and evidence delivery
What we deliver across the product lifecycle
We provide end-to-end clinical support, from early strategy through to study delivery and post-market evidence.
Clinical evidence, studies and trial delivery
We plan and deliver clinical evidence programmes aligned with regulatory requirements and product strategy.
Clinical strategy and planning
Clinical development strategy and evidence planning
Study design and protocol development
Feasibility and site selection
Study delivery and evidence generation
Clinical investigations and trial management
Data collection, analysis and reporting
Regulatory-ready clinical documentation
Clinical evaluation and literature review
Structured literature reviews and evaluation of existing evidence to support regulatory requirements.
Medical writing and documentation
Preparation of clinical documents including protocols, reports and regulatory submissions.
Regulatory-aligned evidence strategy
Align clinical evidence with regulatory requirements and approval pathways.
Clinical investigation management
End-to-end management of clinical studies, from planning through to execution and reporting.
Post-market clinical follow-up
Ongoing studies and evidence generation to support compliance and product lifecycle.
Real-world evidence and data
Use of real-world data to support performance, safety and market adoption.
03 - OUR APPROACH
How we support your clinical strategy
Structured support from planning through to delivery
We work alongside your team to plan, deliver and maintain clinical evidence aligned with your regulatory and commercial goals.
1: Clinical assessment
Review product, indication and evidence requirements to define priorities, evidence needs and the most appropriate clinical route forward.
2: Strategy and study design
Define clinical strategy, study design and an evidence plan aligned with regulatory requirements and product objectives.
3: Study delivery
Execute clinical studies and manage site activity, data collection and monitoring throughout the delivery process.
4: Analysis and reporting
Analyse study data and prepare clear, regulatory-ready documentation to support review, approval and next steps.
5: Ongoing evidence support
Maintain clinical evidence through post-market activities, follow-up studies and ongoing updates across the product lifecycle.
04 - WHO WE SUPPORT
Supporting clinical programmes across the lifecycle
Who we work with
We support organisations across health and medical technology, from early-stage development through to clinical evidence generation and post-market activities.
Who we support across clinical programmes
Medical device and IVD companies
Clinical strategy and study support across development, evidence generation and regulatory requirements.
Established manufacturers
Support to expand clinical evidence, maintain compliance and support product updates and new indications.
Digital health and AI companies
Support for software and AI-enabled products developing clinical evidence and navigating evolving requirements.
Investors and portfolio companies
Clinical input to support evidence planning, product development and growth across portfolios.
Startups and scale-ups
Practical support to define clinical strategy and generate evidence needed for early-stage growth and market entry.
Research and clinical organisations
Support to design and deliver studies that generate meaningful, regulatory-ready clinical evidence.
Speak to the team
Get clear, practical support for your clinical strategy, evidence planning and study delivery.